Stock comparison

JNJvsPFE

Johnson & JohnsonvsPfizer Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JNJ

Johnson & Johnson

$230.65

+9.01%

Pharmaceuticals$585.7BNYSE

PFE

Pfizer Inc

$26.67

+3.17%

Pharmaceuticals$155.1BNYSE

60-day price, rebased to 100

JNJ +1.29% · PFE +3.13%

Round-by-round

JNJ 3·PFE 3

EdgePFE

Valuation upside

-37.60% vs -18.10% to DCF fair value

EdgeJNJ

Balance-sheet strength

Altman Z 5.08 vs 2.15

EdgePFE

Fundamental quality

Piotroski 4.00 vs 6.00 (of 9)

EdgeJNJ

Growth + margins

Rule-of-40 26.60 vs 12.90

EdgePFE

60-day momentum

+1.29% vs +3.13% price return

EdgeJNJ

Market-cap liquidity

$585.7B vs $155.1B

Verdict

Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onJNJorPFE

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.